Loss of KMT5C Promotes EGFR Inhibitor Resistance in NSCLC via LINC01510-Mediated Upregulation of MET. Pal AS, Agredo A, Lanman NA, Son J, et al. Cancer Res 2022;82:1534-1547.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pal AS, Agredo A, Lanman NA, Son J, et al. Loss of KMT5C Promotes EGFR Inhibitor Resistance in NSCLC via LINC01510-Mediated Upregulation of MET. Cancer Res 2022;82:1534-1547.
PMID: 35404406